These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 7521695)
1. Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis. Neubauer A; Fiebeler A; Graham DK; O'Bryan JP; Schmidt CA; Barckow P; Serke S; Siegert W; Snodgrass HR; Huhn D Blood; 1994 Sep; 84(6):1931-41. PubMed ID: 7521695 [TBL] [Abstract][Full Text] [Related]
2. Recent progress on the role of Axl, a receptor tyrosine kinase, in malignant transformation of myeloid leukemias. Neubauer A; Burchert A; Maiwald C; Gruss HJ; Serke S; Huhn D; Wittig B; Liu E Leuk Lymphoma; 1997 Mar; 25(1-2):91-6. PubMed ID: 9130617 [TBL] [Abstract][Full Text] [Related]
3. Noninsulin-dependent diabetes mellitus occurs in mice ectopically expressing the human Axl tyrosine kinase receptor. Augustine KA; Rossi RM; Van G; Housman J; Stark K; Danilenko D; Varnum B; Medlock E J Cell Physiol; 1999 Dec; 181(3):433-47. PubMed ID: 10528229 [TBL] [Abstract][Full Text] [Related]
4. Differential expression of the ufo/axl oncogene in human leukemia-lymphoma cell lines. Challier C; Uphoff CC; Janssen JW; Drexler HG Leukemia; 1996 May; 10(5):781-7. PubMed ID: 8656672 [TBL] [Abstract][Full Text] [Related]
5. Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia (AML): results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK). Rochlitz C; Lohri A; Bacchi M; Schmidt M; Nagel S; Fopp M; Fey MF; Herrmann R; Neubauer A Leukemia; 1999 Sep; 13(9):1352-8. PubMed ID: 10482985 [TBL] [Abstract][Full Text] [Related]
6. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells. Lawrence HJ; Sauvageau G; Ahmadi N; Lopez AR; LeBeau MM; Link M; Humphries K; Largman C Exp Hematol; 1995 Oct; 23(11):1160-6. PubMed ID: 7556525 [TBL] [Abstract][Full Text] [Related]
7. axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. O'Bryan JP; Frye RA; Cogswell PC; Neubauer A; Kitch B; Prokop C; Espinosa R; Le Beau MM; Earp HS; Liu ET Mol Cell Biol; 1991 Oct; 11(10):5016-31. PubMed ID: 1656220 [TBL] [Abstract][Full Text] [Related]
8. Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia. Hong CC; Lay JD; Huang JS; Cheng AL; Tang JL; Lin MT; Lai GM; Chuang SE Cancer Lett; 2008 Sep; 268(2):314-24. PubMed ID: 18502572 [TBL] [Abstract][Full Text] [Related]
9. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells. Drexler HG Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433 [TBL] [Abstract][Full Text] [Related]
11. Gas6/AXL Signaling Regulates Self-Renewal of Chronic Myelogenous Leukemia Stem Cells by Stabilizing β-Catenin. Jin Y; Nie D; Li J; Du X; Lu Y; Li Y; Liu C; Zhou J; Pan J Clin Cancer Res; 2017 Jun; 23(11):2842-2855. PubMed ID: 27852702 [No Abstract] [Full Text] [Related]
12. Axl Blockade by BGB324 Inhibits BCR-ABL Tyrosine Kinase Inhibitor-Sensitive and -Resistant Chronic Myeloid Leukemia. Ben-Batalla I; Erdmann R; Jørgensen H; Mitchell R; Ernst T; von Amsberg G; Schafhausen P; Velthaus JL; Rankin S; Clark RE; Koschmieder S; Schultze A; Mitra S; Vandenberghe P; Brümmendorf TH; Carmeliet P; Hochhaus A; Pantel K; Bokemeyer C; Helgason GV; Holyoake TL; Loges S Clin Cancer Res; 2017 May; 23(9):2289-2300. PubMed ID: 27856601 [No Abstract] [Full Text] [Related]
14. Activation of the Axl receptor tyrosine kinase induces mitogenesis and transformation in 32D cells. McCloskey P; Pierce J; Koski RA; Varnum B; Liu ET Cell Growth Differ; 1994 Oct; 5(10):1105-17. PubMed ID: 7848912 [TBL] [Abstract][Full Text] [Related]
15. TAM receptors and the regulation of erythropoiesis in mice. Tang H; Chen S; Wang H; Wu H; Lu Q; Han D Haematologica; 2009 Mar; 94(3):326-34. PubMed ID: 19211638 [TBL] [Abstract][Full Text] [Related]
16. Expression of the growth arrest-specific gene 6 (GAS6) in leukemia and lymphoma cell lines. Dirks W; Rome D; Ringel F; Jäger K; MacLeod RA; Drexler HG Leuk Res; 1999 Jul; 23(7):643-51. PubMed ID: 10400186 [TBL] [Abstract][Full Text] [Related]
17. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients. Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223 [TBL] [Abstract][Full Text] [Related]
18. Expression of the RET receptor tyrosine kinase and GDNFR-alpha in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow microenvironment. Gattei V; Celetti A; Cerrato A; Degan M; De Iuliis A; Rossi FM; Chiappetta G; Consales C; Improta S; Zagonel V; Aldinucci D; Agosti V; Santoro M; Vecchio G; Pinto A; Grieco M Blood; 1997 Apr; 89(8):2925-37. PubMed ID: 9108413 [TBL] [Abstract][Full Text] [Related]
19. PMA up-regulates the transcription of Axl by AP-1 transcription factor binding to TRE sequences via the MAPK cascade in leukaemia cells. Mudduluru G; Leupold JH; Stroebel P; Allgayer H Biol Cell; 2010 Jan; 103(1):21-33. PubMed ID: 20977427 [TBL] [Abstract][Full Text] [Related]
20. Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapy. Schmidt M; Hochhaus A; König-Merediz SA; Brendel C; Proba J; Hoppe GJ; Wittig B; Ehninger G; Hehlmann R; Neubauer A J Clin Oncol; 2000 Oct; 18(19):3331-8. PubMed ID: 11013272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]